Kyle Miller Email & Phone Number

South Carolina, United States

Charleston, South Carolina Metropolitan Area

South Carolina, East Georgia, NE Florida

• Leveraged account management experience and vaccine expertise to overcome extenuating circumstances and launch Novavax’s first commercial product in SC, GA, and FL markets resulting in over $4.1 million in revenue for.
• Aligned with customer needs to position Novavax as the vaccine of choice in key IDNs, Ind. Pharmacies, and FQHC’s, resulting in finishing #1 in the nation for non-chain retail dose volume – territory accounted for 37%.
• Executed Novavax’s first Physician Buying Group contract which opened up access to our product to over 3,500 pharmacies, Health Systems, FQHC’s, and independent physicians across the nation
• Utilized strategic business planning and a robust understanding of IDN decision-making processes to present GPO contracts to key stakeholders within the top IDNs in the southeast, including MUSC, Prisma Health, UF.
• Collaborated with regional and district leadership within key retailers (CVS/Costco) to educate pharmacy on tactics to increase product utilization and ensure a successful partnership for the 2023/24 immunization season

South Carolina, United States

• Partnered with physician, nursing, and pharmacy leadership within key health systems to grow adult and adolescent immunization rates resulting in 20% Bexsero volume growth and 35% Shingrix volume growth
• Conducted complex contracting conversations with C/D suite executives to maintain and grow existing vaccine portfolio in Prisma Health, Spartanburg Regional, AnMed Health, Mcleod Health, and Self Regional
• Led a team of 5 immunization specialists to successfully execute and pull through strategic business plans in target accounts
• Implemented shingles immunization programs in two large health systems that had previously not included the shingles vaccine on their formulary for in-clinic administration
• Coached and mentored new representatives on selling skills, data analytics, strategic business planning, and the overall vaccine landscape

Charleston, South Carolina Metropolitan Area

• 2021 Circle of Excellence Winner
• 2021 cumulative ranking of #11 out of 521 and 2021 selling team ranking of #4 out of 112
• Influenced key decision makers to implement Shingrix and protocols to maximize the utilization of Shingrix within Mcleod Health, Conway Medical Center, MUSC, and Roper St Francis
• Excelled in yearlong Area Development Program – selected based off performance and career aspirations
• Finished Q4 2020 with Shingrix volume growth at 16% vs STLY ranking in the top 15% of nation
• Received top rating of an “A” at 2020 EOY performance review for 2nd consecutive year, leading to a promotion

Charlottesville, Virginia Area

- Grew Bexsero volume 62% in 2018 and 121% in 2019 (14% MS Growth 2019) - Increased Boostrix market share from 48% to 59% since taking over the territory (goal was 3%)- Increased Menveo market share from 28% to 38% since taking over the territory (goal was 3%)- Responsible for 8.7 million in Shingrix Revenue in 2019- Full portfolio conversions in several.

Columbia, South Carolina

- Generated over $50,000 in sales revenue - Worked 20-25 hours a week as a full-time student - Promoted to Elite Team within first 3 months of employment where sales efforts were focused solely on businesses in the health, legal, and auto industries